Scarica l'app Stockscreener
100.55
0.81%
0.81
Dopo l'orario di chiusura:
100.50
-0.05
-0.05%
Precedente Chiudi:
$99.74
Aprire:
$99.75
Volume 24 ore:
593.66K
Relative Volume:
0.55
Capitalizzazione di mercato:
$4.65B
Reddito:
-
Utile/perdita netta:
$-63.78M
Rapporto P/E:
-37.52
EPS:
-2.68
Flusso di cassa netto:
$-53.91M
1 W Prestazione:
-1.66%
1M Prestazione:
+3.13%
6M Prestazione:
+671.09%
1 anno Prestazione:
+665.80%
Intervallo 1D:
$98.72
$100.99
Intervallo di 1 settimana:
$98.48
$102.36
Portata 52W:
$7.575
$112.64
Celcuity Inc Stock (CELC) Company Profile
Nome
Celcuity Inc
Settore
Industria
Telefono
763-392-0767
Indirizzo
16305 36TH AVENUE N, MINNEAPOLIS, MN
Confronta CELC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
100.55 | 4.62B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | Wells Fargo | Overweight |
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-11-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | Iniziato | Guggenheim | Buy |
| 2025-07-01 | Ripresa | Stifel | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-02-22 | Iniziato | Stifel | Buy |
| 2023-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-07 | Iniziato | Jefferies | Buy |
| 2021-07-29 | Iniziato | Cowen | Outperform |
| 2021-07-27 | Iniziato | Needham | Buy |
| 2021-01-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-11 | Ripresa | Craig Hallum | Buy |
| 2018-11-20 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Celcuity Inc Borsa (CELC) Ultime notizie
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - Star Tribune
Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Trading Systems Reacting to (CELC) Volatility - Stock Traders Daily
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond (NASDAQ:CELC) - Seeking Alpha
Celcuity (CELC)’s Clinical Success and M&A Potential Underpin Wolfe Research’s Bullish View - MSN
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - MSN
Net current asset value per share of Celcuity Inc. – GETTEX:7VR - TradingView — Track All Markets
ETFs Investing in Celcuity Inc. Stocks - TradingView — Track All Markets
Top Biotech Stocks To Add to Your WatchlistDecember 20th - MarketBeat
Does Celcuity Inc. stock trade at a discount to peersJuly 2025 Short Interest & Risk Managed Investment Signals - Улправда
Celcuity (CELC): Reassessing Valuation After New VIKTORIA-1 Breast Cancer Data Boosts Investor Interest - Sahm
Rate Hike: Why Celcuity Inc. stock could be next big winnerMarket Growth Report & Advanced Technical Analysis Signals - Улправда
How Celcuity Inc. stock reacts to job market dataBear Alert & AI Enhanced Trading Alerts - ulpravda.ru
Why Celcuity Inc. stock is trending among retail traders2025 Valuation Update & Scalable Portfolio Growth Ideas - ulpravda.ru
What valuation multiples suggest for Celcuity Inc. stockJuly 2025 Opening Moves & Stock Portfolio Risk Management - Улправда
Aug Retail: How Celcuity Inc. stock reacts to job market dataJuly 2025 Big Picture & Entry Point Strategy Guides - Улправда
(CELC) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Will Celcuity Inc. stock deliver better than expected guidanceIPO Watch & Stepwise Trade Execution Plans - Bölüm Sonu Canavarı
Why Celcuity Inc. stock is a value investor pickJuly 2025 Opening Moves & Risk Managed Investment Strategies - DonanımHaber
How interest rate cuts could boost Celcuity Inc. stockMarket Weekly Review & Growth Focused Stock Reports - DonanımHaber
Rate Cut: Why Celcuity Inc. stock could be next big winnerJuly 2025 Big Picture & AI Powered Market Trend Analysis - Улправда
Why Celcuity Inc. stock is rated strong buyTrade Performance Summary & Risk Managed Investment Entry Signals - ulpravda.ru
Aug Final Week: Why Celcuity Inc. stock could be next big winnerWeekly Trade Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Fundamentals Check: Does Celcuity Inc. stock trade at a discount to peersMarket Sentiment Summary & Weekly Top Gainers Alerts - Улправда
Why Celcuity Inc. stock could be next big winnerMarket Sentiment Report & Fast Gaining Stock Reports - Улправда
Aug Sectors: How Celcuity Inc. stock reacts to job market dataJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Улправда
How Investors Are Reacting To Celcuity (CELC) Gedatolisib’s Phase 3 Breast Cancer Data And Safety Profile - Yahoo Finance
Leerink Partners raises Celcuity stock price target to $118 on gedatolisib outlook - Investing.com Nigeria
Leerink Partners raises Celcuity stock price target to $118 on gedatolisib outlook By Investing.com - Investing.com South Africa
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation - Yahoo Finance
Did Gedatolisib’s Phase 3 PFS and Tolerability Data Just Shift Celcuity’s (CELC) Investment Narrative? - simplywall.st
Celcuity (NASDAQ:CELC) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Celcuity initiated with an overweight at Wells Fargo - MSN
Celcuity (CELC) Valuation Check After Paradigm-Shifting VIKTORIA-1 Breast Cancer Data Update - Sahm
Celcuity (NASDAQ:CELC) Hits New 1-Year HighShould You Buy? - MarketBeat
Eventide Asset Management LLC Buys 123,774 Shares of Celcuity, Inc. $CELC - MarketBeat
Wells Fargo Initiates Coverage of Celcuity (CELC) with Overweight Recommendation - Nasdaq
Is CELC Stock Overpriced? - timothysykes.com
RH Posts Strong Q3 Sales, Joins Canopy Growth, Tilray Brands, Frequency Electronics And Other Big Stocks Moving Higher On Friday - Benzinga
Celcuity stock hits all-time high at 109.15 USD By Investing.com - Investing.com Canada
Celcuity stock hits all-time high at 109.15 USD - Investing.com
Celcuity downgraded to Neutral from Buy at H.C. Wainwright - MSN
Wells Fargo Initiates Celcuity With Overweight Rating, $126 Price Target - marketscreener.com
Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review - MSN
Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank - Finviz
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium - The Manila Times
Celcuity Presents Updated Results from the PIK3CA Wild-Type - GlobeNewswire
Director Cashes Out: Celcuity Stock Sale Revealed! - TipRanks
Richard Buller Sells 3,000 Shares of Celcuity (NASDAQ:CELC) Stock - MarketBeat
Celcuity Inc Azioni (CELC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):